Abstract
Antimicrobial resistance is driven by inappropriate use of antibiotics for acute respiratory infections (ARIs), which is a major challenge in primary care in low- and middle-income countries. Here we conducted a pragmatic, cluster randomized controlled trial in 34 township hospitals in two rural counties of Guangdong, China, to evaluate whether a digitally enabled stewardship program could reduce antibiotic prescribing. The intervention combined training and guidelines for doctors; concise, evidence-based guidelines embedded in the electronic medical record with point-of-care prompts; monthly prescribing peer review feedback for doctors; and patient education delivered through a smartphone app. Control is usual care with no inputs. During the 12-month implementation period (1 March 2020 to 28 February 2021), we analyzed 97,239 eligible consultations for ARIs. The primary outcome was whether a consultation resulted in any antibiotics being prescribed. This outcome was met: antibiotics were prescribed in 26% (14,521/54,799) of intervention consultations compared to 71% (30,340/42,440) of control consultations, yielding an adjusted risk difference of –39 percentage points (95% confidence interval: –47 to –29; P < 0.001). There was no evidence of increased harm, as 30-day hospitalization rates for respiratory illness or sepsis did not differ between groups (adjusted risk difference, 0.2 percentage points; 95% confidence interval: –0.3 to 0.6). A comprehensive stewardship program can substantially reduce inappropriate antibiotic prescribing for ARIs in rural primary care facilities in China without compromising patient safety. Trial registration: ISRCTN96892547.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout



Similar content being viewed by others
Data availability
Anonymized patient-level data underlying the results of this study are held at the Guangzhou Institute of Respiratory Health. Data will be made available for non-commercial research purposes to qualified investigators upon submission of a data access application, which must include a brief study protocol and a signed data use agreement compliant with China’s Public Data Safety Law. Applications should be sent to the corresponding author (N.Z., nanshan@vip.163.com) and will be reviewed by the institutional data access committee. Decisions on access will be provided within 2 months of application, as approvals are required from both the academic institute and the Shaoguan Health Bureau to ensure compliance with current legal and regulatory requirements. Approved applicants will be granted secure access to the data repository for a time-limited period.
Code availability
The statistical code used for the analyses in this study is available for non-commercial research purposes upon submission of a request to the first author (X.W., xiaolin.wei@utoronto.ca) and the chief biostatistician (J.P.H., j.p.hicks@leeds.ac.uk). Applicants must provide a brief description of the intended use and agree to a code-sharing agreement. Requests will be reviewed within 2 weeks, and approved applicants will be provided with the relevant R scripts via a secure repository.
References
GBD 2021 Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance 1990−2021: a systematic analysis with forecasts to 2050. Lancet 404, 1199–1226 (2024).
Butler, C. C. et al. Variation in antibiotic prescribing and its impact on recovery in patients with acute cough in primary care: prospective study in 13 countries. BMJ 338, b2242 (2009).
Prestinaci, F., Pezzotti, P. & Pantosti, A. Antimicrobial resistance: a global multifaceted phenomenon. Pathog. Glob. Health 109, 309–318 (2015).
Sulis, G. et al. Antibiotic prescription practices in primary care in low- and middle-income countries: a systematic review and meta-analysis. PLoS Med. 17, e1003139 (2020).
Kjærgaard, J. et al. Diagnosis and treatment of acute respiratory illness in children under five in primary care in low-, middle-, and high-income countries: a descriptive FRESH AIR study. PLoS ONE 14, e0221389 (2019).
Fu, M. et al. Appropriate use of antibiotics for acute respiratory infections at primary healthcare facilities in China: a nationwide cross-sectional study from 2017 to 2019. Lancet Reg. Health West. Pac. 40, 100880 (2023).
Esmaily, H. M. et al. Can rational prescribing be improved by an outcome-based educational approach? A randomized trial completed in Iran. J. Contin. Educ. Health Prof. 30, 11–18 (2010).
Francis, N. A. et al. Effect of using an interactive booklet about childhood respiratory tract infections in primary care consultations on reconsulting and antibiotic prescribing: a cluster randomised controlled trial. BMJ 339, b2885 (2009).
Juzych, N. S., Banerjee, M., Essenmacher, L. & Lerner, S. A. Improvements in antimicrobial prescribing for treatment of upper respiratory tract infections through provider education. J. Gen. Intern. Med. 20, 901–905 (2005).
Oliveira, I. et al. Systematic review on the impact of guidelines adherence on antibiotic prescription in respiratory infections. Antibiotics (Basel) 9, 546 (2020).
Shen, X. et al. A complex intervention to reduce antibiotic prescribing in rural China: a cluster randomised controlled trial. Lancet Reg. Health West. Pac. 53, 101236 (2024).
Gjelstad, S. et al. Improving antibiotic prescribing in acute respiratory tract infections: cluster randomised trial from Norwegian general practice (prescription peer academic detailing (Rx-PAD) study). BMJ 347, f4403 (2013).
Gerber, J. S. et al. Effect of an outpatient antimicrobial stewardship intervention on broad-spectrum antibiotic prescribing by primary care pediatricians: a randomized trial. JAMA 309, 2345–2352 (2013).
Wei, X. et al. Effect of a training and educational intervention for physicians and caregivers on antibiotic prescribing for upper respiratory tract infections in children at primary care facilities in rural China: a cluster-randomised controlled trial. Lancet Glob. Health 5, e1258–e1267 (2017).
Meeker, D. et al. Effect of behavioral interventions on inappropriate antibiotic prescribing among primary care practices: a randomized clinical trial. JAMA 315, 562–570 (2016).
Feldmeier, G. et al. Optimizing antibiotic prescribing for acute respiratory tract infections in german primary care: results of the regional intervention study CHANGE-3 and the nested cRCT. Antibiotics (Basel) 12, 850 (2023).
Cals, J. W., Butler, C. C., Hopstaken, R. M., Hood, K. & Dinant, G. J. Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial. BMJ 338, b1374 (2009).
Little, P. et al. Effects of internet-based training on antibiotic prescribing rates for acute respiratory-tract infections: a multinational, cluster, randomised, factorial, controlled trial. Lancet 382, 1175–1182 (2013).
Do, N. T. et al. Point-of-care C-reactive protein testing to reduce inappropriate use of antibiotics for non-severe acute respiratory infections in Vietnamese primary health care: a randomised controlled trial. Lancet Glob. Health 4, e633–e641 (2016).
Onwunduba, A., Ekwunife, O. & Onyilogwu, E. Impact of point-of-care C-reactive protein testing intervention on non-prescription dispensing of antibiotics for respiratory tract infections in private community pharmacies in Nigeria: a cluster randomized controlled trial. Int. J. Infect. Dis. 127, 137–143 (2023).
Tan, R. et al. A digital health algorithm to guide antibiotic prescription in pediatric outpatient care: a cluster randomized controlled trial. Nat. Med. 30, 76–84 (2024).
Cals, J. W. et al. Enhanced communication skills and C-reactive protein point-of-care testing for respiratory tract infection: 3.5-year follow-up of a cluster randomized trial. Ann. Fam. Med. 11, 157–164 (2013).
Jenkins, T. C. et al. Effects of clinical pathways for common outpatient infections on antibiotic prescribing. Am. J. Med. 126, 327–335 (2013).
Gulliford, M. C. et al. Electronically delivered interventions to reduce antibiotic prescribing for respiratory infections in primary care: cluster RCT using electronic health records and cohort study. Health Technol. Assess. 23, 1−70 (2019).
Mann, D. et al. Impact of clinical decision support on antibiotic prescribing for acute respiratory infections: a cluster randomized implementation trial. J. Gen. Intern. Med. 35, 788–795 (2020).
Blair, P. S. et al. Multi-faceted intervention to improve management of antibiotics for children presenting to primary care with acute cough and respiratory tract infection (CHICO): efficient cluster randomised controlled trial. BMJ 381, e072488 (2023).
Chang, J. et al. Assessment of non-prescription antibiotic dispensing at community pharmacies in China with simulated clients: a mixed cross-sectional and longitudinal study. Lancet Infect. Dis. 19, 1345–1354 (2019).
Heddini, A., Cars, O., Qiang, S. & Tomson, G. Antibiotic resistance in China—a major future challenge. Lancet 373, 30 (2009).
Wang, X. et al. Massive misuse of antibiotics by university students in all regions of China: implications for national policy. Int. J. Antimicrob. Agents 50, 441–446 (2017).
Zhang, Z. et al. Antibiotic prescribing for upper respiratory infections among children in rural China: a cross-sectional study of outpatient prescriptions. Glob. Health Action 10, 1287334 (2017).
Wang, J., Wang, P., Wang, X., Zheng, Y. & Xiao, Y. Use and prescription of antibiotics in primary health care settings in China. JAMA Intern. Med. 174, 1914–1920 (2014).
Wei, X. et al. Understanding factors influencing antibiotic prescribing behaviour in rural China: a qualitative process evaluation of a cluster randomized controlled trial. J. Health Serv. Res. Policy 25, 94–103 (2020).
Zhuo, C. et al. An antibiotic stewardship programme to reduce inappropriate antibiotic prescribing for acute respiratory infections in rural Chinese primary care facilities: study protocol for a clustered randomised controlled trial. Trials 21, 394 (2020).
Lewnard, J. A. et al. Burden of bacterial antimicrobial resistance in low-income and middle-income countries avertible by existing interventions: an evidence review and modelling analysis. Lancet 403, 2439–2454 (2024).
Hallsworth, M. et al. Provision of social norm feedback to high prescribers of antibiotics in general practice: a pragmatic national randomised controlled trial. Lancet 387, 1743–1752 (2016).
Gulliford, M. C. et al. Effectiveness and safety of electronically delivered prescribing feedback and decision support on antibiotic use for respiratory illness in primary care: REDUCE cluster randomised trial. BMJ 364, l236 (2019).
Schwartz, K. L. et al. Effect of antibiotic-prescribing feedback to high-volume primary care physicians on number of antibiotic prescriptions: a randomized clinical trial. JAMA Intern. Med. 181, 1165–1173 (2021).
Hu, Y. et al. Interventions to reduce childhood antibiotic prescribing for upper respiratory infections: systematic review and meta-analysis. J. Epidemiol. Community Health 70, 1162–1170 (2016).
Tonkin-Crine, S. K. et al. Clinician-targeted interventions to influence antibiotic prescribing behaviour for acute respiratory infections in primary care: an overview of systematic reviews. Cochrane Database Syst. Rev. 9, CD012252 (2017).
Wei, X. et al. Long-term outcomes of an educational intervention to reduce antibiotic prescribing for childhood upper respiratory tract infections in rural China: follow-up of a cluster-randomised controlled trial. PLoS Med. 16, e1002733 (2019).
National Health and Family Planning Commission of the People's Republic of China. National Antimicrobial Therapy Guidelines [in Chinese] (People's Medical Publishing House, 2017).
Benson, V. S. et al. Disease burden, treatment patterns and asthma control in adult patients with asthma in China: a real-world study. J. Asthma Allergy 17, 949–964 (2024).
Koch, M. et al. Characteristics and health burden of the undiagnosed population at risk of chronic obstructive pulmonary disease in China. BMC Public Health 19, 1727 (2019).
Hansson, L., Hedner, T. & Dahlof, B. Prospective randomized open blinded end-point (PROBE) study. A novel design for intervention trials. Blood Press. 1, 113–119 (1992).
Antimicrobial stewardship programmes in health-care facilities in low- and middle-income countries: WHO practical toolkit. https://www.who.int/publications/i/item/9789241515481 (World Health Organization, 2019).
Respiratory tract infections (self-limiting): prescribing antibiotics. https://www.nice.org.uk/guidance/cg69 (National Institute for Health and Care Excellence, 2008).
Köchling, A. et al. Reduction of antibiotic prescriptions for acute respiratory tract infections in primary care: a systematic review. Implement. Sci. 13, 47 (2018).
Steinman, M. A., Landefeld, C. S. & Gonzales, R. Predictors of broad-spectrum antibiotic prescribing for acute respiratory tract infections in adult primary care. JAMA 289, 719–725 (2003).
WHO Model List of Essential Medicines. https://www.who.int/groups/expert-committee-on-selection-and-use-of-essential-medicines/essential-medicines-lists (World Health Organization, 2019).
Kahan, B. C., Li, F., Copas, A. J. & Harhay, M. O. Estimands in cluster-randomized trials: choosing analyses that answer the right question. Int. J. Epidemiol. 52, 107–118 (2022).
ICH E9 (R1) addendum on estimands and sensitivity analysis in clinical trials to the guideline on statistical principles for clinical trials. https://www.ema.europa.eu/en/documents/scientific-guideline/ich-e9-r1-addendum-estimands-sensitivity-analysis-clinical-trials-guideline-statistical-principles_en.pdf (2020).
Norton, E. C., Dowd, B. E. & Maciejewski, M. L. Marginal effects-quantifying the effect of changes in risk factors in logistic regression models. JAMA 321, 1304–1305 (2019).
Ren, S. et al. Nonparametric bootstrapping for hierarchical data. J. Appl. Stat. 37, 1487–1498 (2010).
Efron, B. & Tibshirani, R. J. An Introduction to the Bootstrap (Chapman & Hall/CRC, 1993).
Holmberg, M. J. & Andersen, L. W. Adjustment for baseline characteristics in randomized clinical trials. JAMA 328, 2155–2156 (2022).
Malehi, A. S., Pourmotahari, F. & Angali, K. A. Statistical models for the analysis of skewed healthcare cost data: a simulation study. Health Econ. Rev. 5, 11 (2015).
Desai, M., Pieper, K. S. & Mahaffey, K. Challenges and solutions to pre- and post-randomization subgroup analyses. Curr. Cardiol. Rep. 16, 531 (2014).
Tchetgen Tchetgen, E. J., Phiri, K. & Shapiro, R. A simple regression-based approach to account for survival bias in birth outcomes research. Epidemiology 26, 473–480 (2015).
Acknowledgements
The authors acknowledge the support provided by the 36 township hospitals, including 34 in the trial and two in the pilot, in Shaoguan Prefecture, China, which were directly involved in the pilot and endline periods. We thank all patients and/or caregivers and healthcare providers who were involved in the trial. The study was funded by the China Primary Health Care Foundation (awarded to C.Z., X.W. and J.Z.). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.
Author information
Authors and Affiliations
Contributions
X.W., J.P.H., C.Z., Z.Z. and N.Z. contributed to the study design. X.W., C.Z., J.D.W., Z.Z., J.Z., W.G. and H.H. contributed to guideline development, training and implementation. X.W. and J.P.H. drafted the manuscript, with support from Z.Z. and S.W., and N.Z., C.Z., F.S. and A.B. commented on the manuscript. Z.Z. prepared and cleaned the data. J.P.H. analyzed the data and provided substantial scientific input in statistical methods and interpretation of results. N.Z. is the overall lead of the research consortium. The corresponding authors attest that all listed authors meet authorship criteria and that no others meeting the criteria have been omitted.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature Medicine thanks Rainer Tan and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Peer reviewer reports are available. Primary Handling Editor: Ming Yang, in collaboration with the Nature Medicine team.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Extended data
Extended Data Fig. 1 Endline antibiotic prescription rate per intervention-group township hospital.
Bars indicate the antibiotic prescription rate (the percentage of eligible consultations where any acute respiratory infection[s] were diagnosed that resulted in any antibiotics being prescribed) across the endline period for each township hospital in the intervention group only. The 10th percentile (18%), mean (26.5%) and 90th (35%) percentile of those values are also illustrated (interquartile range = 10.3). Township hospitals are ordered by their endline antibiotic prescription rate.
Extended Data Fig. 2 Percentage point change in antibiotic prescription rate between baseline and endline per cluster.
APR = antibiotic prescription rate. Bars and values indicate the percentage point change in the antibiotic prescription rate between the baseline period and the endline period for each cluster, where the antibiotic prescription rate is the percentage of eligible patient consultations (where an acute respiratory infection was diagnosed) that resulted in any antibiotics.
Extended Data Fig. 3 Hospitalisation rate within 30 days after an eligible patient consultation in a township hospital by month (actual timeline) and treatment group.
Diamonds/squares and values represent the percentage of eligible patient consultations (where an acute respiratory infection was diagnosed) where the patient was subsequently hospitalised in any hospital within the Shaoguan Prefecture within 30 days of that consultation for the indicated treatment group and month relative to when the intervention started being implemented. The suspended period occurred when COVID-19 pandemic restrictions closed township hospitals and the trial was suspended.
Supplementary information
Supplementary Information
CONSORT checklist, Trial protocol and Statistical analysis plan.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Wei, X., Zhuo, C., Hicks, J.P. et al. Effects of a comprehensive antibiotic stewardship program on antibiotic prescribing for acute respiratory infections in rural facilities: a cluster randomized trial. Nat Med (2026). https://doi.org/10.1038/s41591-026-04222-y
Received:
Accepted:
Published:
Version of record:
DOI: https://doi.org/10.1038/s41591-026-04222-y


